Evaluating the Responsiveness and Determining Clinical Significance for PRO Measures
View Presentation *Dennis Revicki, Center for Health Outcomes Research Keywords: Patient Reported Outcomes, Responder Analyses Dr. Dennis Revicki, Sr Vice President and Scientific Director, Center for Health Outcomes Research, is a psychometrician with over 25 yrs experience in developing and validating patient reported outcome (PRO) measures and in the analysis and interpretation of PRO data from clinical trials. Evaluating the responsiveness and providing interpretation guidance for PRO measures are critical for understanding these endpoints in clinical trials. This presentation will discuss methods for evaluating responisveness and for determining the clinical significance of changes or differences in PRO measures. There are uncertainties about the best approaches for identifying values for interpreting clinical significance of differences between group mean changes in PRO measures and for responder analyses. This presentation will provide guidance on the best methods for determining clinical significance.
|
Key Dates
-
April 30 - May 22, 2013
Invited Abstract Submission Open -
June 4, 2013
Online Registration Opens -
August 9 - August 23, 2013
Invited Abstract Editing -
August 23, 2013
Short Course materials due from Instructors -
August 26, 2013
Housing Deadline -
September 9, 2013
Cancellation Deadline and Registration Closes @ 11:59 pm EDT -
September 16 - September 18, 2013
Marriott Wardman Park, Washington, DC